Very Strong Cash Position heading into the commercialisation Phase. Would really like to know more about the progress of Diatranz Otsuka Limited though, LCT must receive updates as we own 50% of the joint venture?
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
1AI
algorae pharmaceuticals limited
Add to My Watchlist
0.00%
!
0.5¢

Very Strong Cash Position heading into the commercialisation...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.436M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $346 | 69.12K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 2490418 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 3429885 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 2490418 | 0.005 |
13 | 9572708 | 0.004 |
7 | 10463302 | 0.003 |
3 | 3650009 | 0.002 |
5 | 6915013 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 3429885 | 6 |
0.007 | 4239995 | 6 |
0.008 | 227572 | 4 |
0.009 | 1664380 | 3 |
0.010 | 2204715 | 3 |
Last trade - 12.09pm 04/07/2025 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online